Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-26
2007-06-26
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S284100
Reexamination Certificate
active
11494697
ABSTRACT:
The invention provides compounds of the formula:wherein (a) is a single or double bond; W is CH, CH2, CHCH3, C(CH3)2, C(CH2)2or C(CH2)3; X is N; and Y is H or F, and salts, hydrates, tautomers, pure enantiomers, and enantiomeric mixtures; and a method of treating schizophrenia comprising administering same.
REFERENCES:
patent: 6417222 (2002-07-01), Vacher et al.
patent: 05-125024 (1993-05-01), None
patent: 99/51575 (1999-10-01), None
patent: 99/58527 (1999-11-01), None
patent: 00/58282 (2000-10-01), None
Yunusaga, T. et al., “Preparation of(hetero)aryloxyalkylamine derivatives having selective affinity to serotonin(5-HT 1A)receptors”, Chemical Abstracts, Oct. 25, 1993, Abstract No. 180657, vol. 119, No. 17, Chemical Abstracts Service, Columbus, OH, USA, abstract of JP05-125024.
Colpaert Francis
Cuisiat Stéphane
Koek Wouter
Vacher Bernard
Buchanan & Ingersoll & Rooney PC
Morris Patricia L.
Pierre Fabre Medicament
LandOfFree
3-(cyclopenten-1-yl)-benzyl-or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(cyclopenten-1-yl)-benzyl-or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(cyclopenten-1-yl)-benzyl-or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3852337